Boardroom / Unsplash

Digital-first payment solutions provider Soft2Pay has appointed Yosef Kamel as its CEO and Steve Seguna as its Head of Risk and Compliance.

Mr Kamel’s appointment was announced on Wednesday. He brings extensive experience to his new role.

When sharing the announcement on his LinkedIn profile Mr Kamel expressed his enthusiasm for joining the dynamic team at Soft2Pay, stating that he looks forward to driving impactful results for the company.

Prior to joining Soft2Pay, Mr Kamel held the role of Director of Business Development – Forex/Trading at AstroPay, where he gained “invaluable experience.”

CEO Yosef Kamel / LinkedIn

Meanwhile, Mr Seguna’s announcement came on Thursday (today).

“I’m excited to collaborate with such a talented, forward-thinking team and to contribute my experience in driving meaningful impact in risk management and compliance,” he stated.

Reacting to the news, Mr Kamel noted that Mr Seguna has “a wealth of experience” having spent over a decade in risk management, anti-fraud and AML within the iGaming and financial services sectors.

Steve Seguna / LinkedIn

His career included roles at companies such as ComeOn Group, Videoslots, Bank of Valletta plc, and NetEnt, where he worked on payments, fraud prevention, risk analysis, and regulatory compliance.

Related

Mark Drago named Chief Operating Officer at HSBC Malta

3 July 2025
by Adel Montanaro

Mr Drago is taking over from Svetlana Maslova, bringing over 38 years of banking experience.

Kyte Global supports companies in achieving DORA and MiCA compliance following their release

2 July 2025
by MaltaCEOs

With new EU regulations on digital resilience and crypto-assets set to take effect in 2025, Kyte Global is supporting organisations ...

Corinthia Group Managing Director and CEO recognised with international award

2 July 2025
by Adel Montanaro

Simon Naudi was awarded the Exceptional Contribution CEO Award from Global Hotel Alliance.

Alexander Fenech takes on strategy role at Brown’s as Tiziana Ceci named CEO

2 July 2025
by Adel Montanaro

The pharmacy chain also announced the addition of two independent directors to its board.